AI-generated summary
The authors randomized 60 patients with carpal tunnel syndrome to active low-level laser at two doses or placebo, in a double-blind design over three weeks. All groups improved on several measures, but the authors report no significant difference among the groups, suggesting the laser was no more effective than placebo with the regimen used.
- Participants
- 60
- Who or what was studied
- Patients with carpal tunnel syndrome
- Limits stated in the abstract
- The abstract does not state the laser wavelength, and the study used a single laser type and dose regimen, so the findings may not generalize to other settings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Visual analogue scale, Placebo-controlled, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.